Evidence map›Paper›PMID 23760506›Full record

ArticleThe Journal of biological chemistry2013

O-glycosylation as a novel control mechanism of peptidoglycan hydrolase activity.

Thomas Rolain, Elvis Bernard, Audrey Beaussart, Hervé Degand, Pascal Courtin, Wolfgang Egge-Jacobsen, Peter A Bron, Pierre Morsomme, Michiel Kleerebezem, Marie-Pierre Chapot-Chartier and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Study of theFrontiers in microbiology · 2020
    Article
  10. The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.International journal of molecular sciences · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. The sweet tooth of bacteria: common themes in bacterial glycoconjugates.Microbiology and molecular biology reviews : MMBR · 2014
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Thomas RolainInstitut des Sciences de la Vie, Université catholique de Louvain, B-1348 Louvain-la-Neuve, Belgium.
Elvis Bernard
Audrey Beaussart
Hervé Degand
Pascal Courtin
Wolfgang Egge-Jacobsen
Peter A Bron
Pierre Morsomme
Michiel Kleerebezem
Marie-Pierre Chapot-Chartier
Yves F Dufrêne
Pascal Hols
UCLouvain · BEAgroParisTech · FRCancer Genomics Centre · NLUniversity of Oslo · NOWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acm2, the major autolysin of Lactobacillus plantarum, is a tripartite protein. Its catalytic domain is surrounded by an O-glycosylated N-terminal region rich in Ala, Ser, and Thr (AST domain), which is of low complexity and unknown function, and a C-terminal region composed of five SH3b peptidoglycan (PG) binding domains. Here, we investigate the contribution of these two accessory domains and of O-glycosylation to Acm2 functionality. We demonstrate that Acm2 is an N-acetylglucosaminidase and identify the pattern of O-glycosylation (21 mono-N-acetylglucosamines) of its AST domain. The O-glycosylation process is species-specific as Acm2 purified from Lactococcus lactis is not glycosylated. We therefore explored the functional role of O-glycosylation by purifying different truncated versions of Acm2 that were either glycosylated or non-glycosylated. We show that SH3b domains are able to bind PG and are responsible for Acm2 targeting to the septum of dividing cells, whereas the AST domain and its O-glycosylation are not involved in this process. Notably, our data reveal that the lack of O-glycosylation of the AST domain significantly increases Acm2 enzymatic activity, whereas removal of SH3b PG binding domains dramatically reduces this activity. Based on this antagonistic role, we propose a model in which access of the Acm2 catalytic domain to its substrate may be hindered by the AST domain where O-glycosylation changes its conformation and/or mediates interdomain interactions. To the best of our knowledge, this is the first time that O-glycosylation is shown to control the activity of a bacterial enzyme.

Indexed as

AcetylglucosaminidaseAmino Acid SequenceGlycosylationLactiplantibacillus plantarumMicroscopy, Atomic ForceMicroscopy, FluorescenceMolecular Sequence DataN-Acetylmuramoyl-L-alanine AmidaseSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAcetylglucosaminidaseN-Acetylmuramoyl-L-alanine AmidaseAutolysinBacterial SH3b DomainCell Surface EnzymesCell WallGlycoproteinGlycoside HydrolasesLactobacillusN-AcetylglucosaminidaseO-GlycosylationPeptidoglycan

Identifiers

PMID23760506
PMCPMC3829315
OpenAlexW2102956539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.